Similarly, cinnamon has been studied for its antioxidative effects as well and a blinded trial in NAFLD patients by Askari et al. reported that 1500 mg of cinnamon supplementation for 12 weeks reduced AST, ALT, and insulin resistance compared to the placebo group [102]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.